Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions

Abstract Background Chronic musculoskeletal pain (CMP) may lead to reduced physical function and is the most common cause of chronic non-cancer pain. Currently, the pharmacotherapeutic options against CMP are limited and frequently consist of pain management with non-steroidal anti-inflammatories, g...

Full description

Bibliographic Details
Main Authors: Daniela Furrer, Edeltraut Kröger, Martine Marcotte, Nathalie Jauvin, Richard Bélanger, Mark Ware, Guillaume Foldes-Busque, Michèle Aubin, Pierre Pluye, Clermont E. Dionne
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Journal of Cannabis Research
Subjects:
Online Access:https://doi.org/10.1186/s42238-021-00096-8
_version_ 1818578687282380800
author Daniela Furrer
Edeltraut Kröger
Martine Marcotte
Nathalie Jauvin
Richard Bélanger
Mark Ware
Guillaume Foldes-Busque
Michèle Aubin
Pierre Pluye
Clermont E. Dionne
author_facet Daniela Furrer
Edeltraut Kröger
Martine Marcotte
Nathalie Jauvin
Richard Bélanger
Mark Ware
Guillaume Foldes-Busque
Michèle Aubin
Pierre Pluye
Clermont E. Dionne
author_sort Daniela Furrer
collection DOAJ
description Abstract Background Chronic musculoskeletal pain (CMP) may lead to reduced physical function and is the most common cause of chronic non-cancer pain. Currently, the pharmacotherapeutic options against CMP are limited and frequently consist of pain management with non-steroidal anti-inflammatories, gabapentinoids, or opioids, which carry major adverse effects. Although the effectiveness of medical cannabis (MC) for CMP still lacks solid evidence, several patients suffering from it are exploring this therapeutic option with their physicians. Objectives Little is known about patients’ perceptions of their MC treatment for CMP. We aimed to increase this knowledge, useful for healthcare professionals and patients considering this treatment, by conducting a scoping literature review, following guidance by Arksey and O’Malley, to describe the views and perceptions of adult patients who had consumed MC to relieve chronic CMP. Methods Databases (PUBMED, EMBASE, Web of Science) and websites were searched using combinations of controlled and free vocabulary. All studies and study designs reporting on patients’ perceptions regarding MC against CMP were considered. Studies had to include adult patients reporting qualitatively or quantitatively, i.e., through questionnaires, on MC use to treat CMP or other non-cancer pain, since studies reporting exclusively on perceptions regarding CMP were very rare. Study characteristics were extracted and limitations of the study quality were assessed. The review includes patients’ demographic characteristics, patterns of MC use, perceived positive and negative effects, use of alcohol or other drugs, reported barriers to CM use, and funding sources of the studies. Results Participants of the 49 included studies reported that MC use helped them to reduce CMP and other chronic non-cancer pain, with only minor adverse effects, and some reported improved psychological well-being. In the included studies, men represent between 18 and 88% of the subjects. The mean age of participants in these studies (42/49) varied between 28.4 and 62.8 years old. The most common route of administration is inhalation. Conclusion MC users suffering from CMP or other chronic non-cancer pain perceived more benefits than harms. However, the information from these studies has several methodological limitations and results are exploratory. These user-reported experiences must thus be examined by well-designed and methodologically sound clinical or observational studies, particularly regarding CMP, where reports are very scarce.
first_indexed 2024-12-16T06:49:46Z
format Article
id doaj.art-af12794e32bc4c4daf84b60a3733d2d6
institution Directory Open Access Journal
issn 2522-5782
language English
last_indexed 2024-12-16T06:49:46Z
publishDate 2021-09-01
publisher BMC
record_format Article
series Journal of Cannabis Research
spelling doaj.art-af12794e32bc4c4daf84b60a3733d2d62022-12-21T22:40:26ZengBMCJournal of Cannabis Research2522-57822021-09-013112810.1186/s42238-021-00096-8Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptionsDaniela Furrer0Edeltraut Kröger1Martine Marcotte2Nathalie Jauvin3Richard Bélanger4Mark Ware5Guillaume Foldes-Busque6Michèle Aubin7Pierre Pluye8Clermont E. Dionne9Centre d’excellence sur le vieillissement de Québec (CEVQ), Centre Intégré Universitaire de Santé et de Services Sociaux de la Capitale-Nationale (CIUSSSCN)Centre d’excellence sur le vieillissement de Québec (CEVQ), Centre Intégré Universitaire de Santé et de Services Sociaux de la Capitale-Nationale (CIUSSSCN)Centre d’excellence sur le vieillissement de Québec (CEVQ), Centre Intégré Universitaire de Santé et de Services Sociaux de la Capitale-Nationale (CIUSSSCN)Centre d’excellence sur le vieillissement de Québec (CEVQ), Centre Intégré Universitaire de Santé et de Services Sociaux de la Capitale-Nationale (CIUSSSCN)Faculty of Pharmacy, Université LavalFaculty of Medicine, McGill UniversitySchool of Psychology, Université LavalCentre d’excellence sur le vieillissement de Québec (CEVQ), Centre Intégré Universitaire de Santé et de Services Sociaux de la Capitale-Nationale (CIUSSSCN)Faculty of Medicine, McGill UniversityCentre d’excellence sur le vieillissement de Québec (CEVQ), Centre Intégré Universitaire de Santé et de Services Sociaux de la Capitale-Nationale (CIUSSSCN)Abstract Background Chronic musculoskeletal pain (CMP) may lead to reduced physical function and is the most common cause of chronic non-cancer pain. Currently, the pharmacotherapeutic options against CMP are limited and frequently consist of pain management with non-steroidal anti-inflammatories, gabapentinoids, or opioids, which carry major adverse effects. Although the effectiveness of medical cannabis (MC) for CMP still lacks solid evidence, several patients suffering from it are exploring this therapeutic option with their physicians. Objectives Little is known about patients’ perceptions of their MC treatment for CMP. We aimed to increase this knowledge, useful for healthcare professionals and patients considering this treatment, by conducting a scoping literature review, following guidance by Arksey and O’Malley, to describe the views and perceptions of adult patients who had consumed MC to relieve chronic CMP. Methods Databases (PUBMED, EMBASE, Web of Science) and websites were searched using combinations of controlled and free vocabulary. All studies and study designs reporting on patients’ perceptions regarding MC against CMP were considered. Studies had to include adult patients reporting qualitatively or quantitatively, i.e., through questionnaires, on MC use to treat CMP or other non-cancer pain, since studies reporting exclusively on perceptions regarding CMP were very rare. Study characteristics were extracted and limitations of the study quality were assessed. The review includes patients’ demographic characteristics, patterns of MC use, perceived positive and negative effects, use of alcohol or other drugs, reported barriers to CM use, and funding sources of the studies. Results Participants of the 49 included studies reported that MC use helped them to reduce CMP and other chronic non-cancer pain, with only minor adverse effects, and some reported improved psychological well-being. In the included studies, men represent between 18 and 88% of the subjects. The mean age of participants in these studies (42/49) varied between 28.4 and 62.8 years old. The most common route of administration is inhalation. Conclusion MC users suffering from CMP or other chronic non-cancer pain perceived more benefits than harms. However, the information from these studies has several methodological limitations and results are exploratory. These user-reported experiences must thus be examined by well-designed and methodologically sound clinical or observational studies, particularly regarding CMP, where reports are very scarce.https://doi.org/10.1186/s42238-021-00096-8Medical cannabisMusculoskeletal painChronic painNon-cancer chronic painPerceived effectsAdverse effect
spellingShingle Daniela Furrer
Edeltraut Kröger
Martine Marcotte
Nathalie Jauvin
Richard Bélanger
Mark Ware
Guillaume Foldes-Busque
Michèle Aubin
Pierre Pluye
Clermont E. Dionne
Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions
Journal of Cannabis Research
Medical cannabis
Musculoskeletal pain
Chronic pain
Non-cancer chronic pain
Perceived effects
Adverse effect
title Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions
title_full Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions
title_fullStr Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions
title_full_unstemmed Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions
title_short Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions
title_sort cannabis against chronic musculoskeletal pain a scoping review on users and their perceptions
topic Medical cannabis
Musculoskeletal pain
Chronic pain
Non-cancer chronic pain
Perceived effects
Adverse effect
url https://doi.org/10.1186/s42238-021-00096-8
work_keys_str_mv AT danielafurrer cannabisagainstchronicmusculoskeletalpainascopingreviewonusersandtheirperceptions
AT edeltrautkroger cannabisagainstchronicmusculoskeletalpainascopingreviewonusersandtheirperceptions
AT martinemarcotte cannabisagainstchronicmusculoskeletalpainascopingreviewonusersandtheirperceptions
AT nathaliejauvin cannabisagainstchronicmusculoskeletalpainascopingreviewonusersandtheirperceptions
AT richardbelanger cannabisagainstchronicmusculoskeletalpainascopingreviewonusersandtheirperceptions
AT markware cannabisagainstchronicmusculoskeletalpainascopingreviewonusersandtheirperceptions
AT guillaumefoldesbusque cannabisagainstchronicmusculoskeletalpainascopingreviewonusersandtheirperceptions
AT micheleaubin cannabisagainstchronicmusculoskeletalpainascopingreviewonusersandtheirperceptions
AT pierrepluye cannabisagainstchronicmusculoskeletalpainascopingreviewonusersandtheirperceptions
AT clermontedionne cannabisagainstchronicmusculoskeletalpainascopingreviewonusersandtheirperceptions